A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

Holdsworth House Medical Practice /ID# 215352, Darlinghurst

St Vincent's Hospital Sydney /ID# 215354, Darlinghurst

The Royal Melbourne Hospital /ID# 215351, Parkville

Orlando Immunology Center /ID# 243276, Orlando

University of Miami, Miller School of Medicine /ID# 213833, Miami

Midway Immunology and Research /ID# 215587, Ft. Pierce

North TX Infectious Diseases /ID# 224861, Dallas

Ruane Clinical Research Group /ID# 224866, Los Angeles

Franco Felizarta, Md /Id# 215721, Bakersfield

Quest Clinical Research /ID# 215796, San Francisco

George Washington University Medical Faculty Associates /ID# 213893, Washington D.C.

Triple O Research Institute /ID# 224863, West Palm Beach

Be Well Medical Center /ID# 223841, Berkley

Mayo Clinic - Rochester /ID# 217820, Rochester

Saint Michael's Medical Center /ID# 228733, Newark

University of Cincinnati /ID# 215615, Cincinnati

Prism Health North Texas - Oak Cliff Health Center /ID# 214036, Dallas

Peter Shalit, M.D. /ID# 224870, Seattle

Ottawa Hospital Research Institute /ID# 218083, Ottawa

Toronto General Hospital /ID# 218082, Toronto

McGill Univ Clinical Research /ID# 218081, Montreal

Clinical Research Puerto Rico /ID# 218821, San Juan

Puerto Rico AIDS Clinical Trials Unit CRS /ID# 213761, San Juan